Drug Marketing
Cross-source consensus on Drug Marketing from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Preparation
Risks & contraindications
Comparisons
Background
Highlighted claims
- The article distinguishes legitimate off-label prescribing by doctors from illegal or fraudulent off-label marketing by companies. — Big Pharma and the Corruption of Medical Knowledge
- The article criticizes U.S. prescription drug advertising to consumers while noting that commercial speech protections may make an outright ban difficult. — Big Pharma and the Corruption of Medical Knowledge
- Neurontin is presented as an example of a drug allegedly marketed for many unapproved uses after approval for narrower indications. — Big Pharma and the Corruption of Medical Knowledge
- The article proposes that prescription drug advertisements should leave viewers with a true impression of medical and economic value. — Big Pharma and the Corruption of Medical Knowledge
- Advertisements could be required to disclose whether a drug is best, whether cheaper equivalent alternatives exist, and how many people must be treated for one person to benefit. — Big Pharma and the Corruption of Medical Knowledge